Therapy News and Research

RSS

Are higher doses and higher costs for cholesterol drugs worth the extra money?

When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years.

24 Apr 2007

Naturally occurring compound found in many fruits and vegetables as well as red wine, selectively kills leukemia cells

These findings, which were published online March 20 in the Journal of Biological Chemistry and will be in press on May 4, offer hope for a more selective, less toxic therapy for leukemia.

24 Apr 2007

Rabies kills three despite proven experimental treatment

According to the Centers for Disease Control and Prevention (CDC) in the United States an experimental rabies treatment that saved the life of a Wisconsin teenager in 2004 has failed to help other children infected with the deadly virus.

23 Apr 2007

Students who hit the bottle increase their risk of heart problems

According to a study in the U.S., college students who over indulge in alcohol are increasing their risk for future heart disease.

22 Apr 2007

Why bladder cancer hits more men than women

Scientists have discovered one of the reasons why bladder cancer is so much more prevalent in men than women: A molecular receptor or protein that is much more active in men than women plays a role in the development of the disease.

21 Apr 2007

Outcomes of primary cryotherapy for prostate cancer

In the February 2007 issue of Urology, Dr. Ellis from the Urology Associates of North Texas reports on a large series of patients treated with primary cryotherapy for prostate cancer (CaP).

21 Apr 2007

Researchers want to learn if heart defect 'at heart' of some migraines

Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.

21 Apr 2007

Knocking out Mcl1 protein could aid leukemia treatment

An effective way to fight leukemia might be to knock out a specific protein that protects cancer cells from dying, a new study shows.

21 Apr 2007

Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer

Results from the Million Women Study, which is the biggest study of its kind in the world, show that over five years there is one extra case of ovarian cancer in every 2,500 women who take HRT. And for every 3,300 women who take HRT, there will be one additional death from ovarian cancer.

20 Apr 2007

Lawmakers urged to provide much needed oversight of bioidentical hormones

Testifying before the United States Senate Special Committee on Aging, Dr. Leonard Wartofsky, president of The Endocrine Society strongly urged lawmakers to increase regulatory oversight of so-called "bioidentical hormones," which have been inaccurately promoted as a safer and more effective alternative to traditional hormone therapies for women.

20 Apr 2007

Schering-Plough announces ZETIA spproved in Japan

Schering-Plough Corporation has announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for ZETIA (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestine.

20 Apr 2007

Risk and outcome similar for bypass surgery, drug-eluting stents

Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures, researchers reported at the American Heart Association's 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.

20 Apr 2007

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Schering-Plough Corporation has announced plans to initiate two global Phase III large-scale clinical outcomes trials for its novel selective oral antiplatelet therapy, the thrombin receptor antagonist (TRA) SCH 530348.

20 Apr 2007

Response to paper on ovarian cancer in the Million Women study

The Million Women Study (MWS) has reported new data on the risk of ovarian cancer in postmenopausal hormone users(1).

20 Apr 2007

Childhood sarcoma increases risk of blood clots

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event (TE) in their veins.

20 Apr 2007

Study evaluates CaP risk among finasteride users

Current medical management for BPH includes alpha-blockers and 5- reductase inhibitors.

20 Apr 2007

Prostate cancer treatment decisions can be complicated

For many men with early-stage prostate cancer, sorting out the treatment options can be overwhelming.

20 Apr 2007

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

20 Apr 2007

New method predicts hip joint decay from chemotherapy

Investigators at St. Jude Children's Research Hospital say they have found the best way for predicting when patients will need future surgery to repair hip joints that have deteriorated because of pediatric leukemia or lymphoma treatment.

20 Apr 2007

New anti-rejection medication 6-month results for heart transplant recipients to be released

New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007.

20 Apr 2007